JX09 SAD/MAD in Healthy Participants

Clinical trial NCT06183671 · UNKNOWN

Trial details

NCT number: NCT06183671
Sponsor: Ji Xing Pharmaceuticals Australia Pty Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Resistant Hypertension

Start date: 2024-01-18
Primary completion: 2024-12-31
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.